Clinical Trial Update: Randomized Trial of Hydrocortisone in Very Preterm High-Risk Infants [Phase 2]

View source ↗

Summary

A randomized Phase 2 trial evaluating hydrocortisone in very preterm high-risk infants has completed, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia
• Encephalomalacia

Drugs mentioned

• HYDROCORTISONE (HYDROCORTISONE)

Snippet

Sponsor: Nationwide Children's Hospital | Conditions: Bronchopulmonary Dysplasia, Encephalomalacia | Phase 2 | Status: COMPLETED | Results posted: 2013-08-30